Toward Precision Antimicrobial Medicine: Converging Phage Therapy, CRISPR, Nanotechnology, and Artificial Intelligence against Antimicrobial Resistance

Key Points

• The aim is to explore new approaches for tackling antimicrobial resistance using advanced technologies.
• Utilized a combination of phage therapy, CRISPR, nanotechnology, and artificial intelligence.
• Targeted a diverse international audience to assess effectiveness.
• Employed comparative analyses to evaluate outcomes.
• Increased effectiveness in reducing antimicrobial resistance rates with combined therapies.
• Enhanced targeting accuracy noted through AI integration.
• Significant improvements in patient outcomes observed across diverse demographics.